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ABSTRACTA
PIn 2009, a publicly transparent evidence-informed process re-
sponded to the requirement of the Children’s Health Insurance
Program Reauthorization Act (CHIPRA) legislation to identify
an initial core set of recommended children’s health care quality
measures for voluntary use by Medicaid and the Children’s
Health Insurance Program, which together cover almost 40
million of America’s children and adolescents. Future efforts
under CHIPRAwill be used to improve and strengthen the initial
core set, develop new measures as needed, and post improved
core measure sets annually beginning in January 2013.
This supplement aims to make available useful information
about issues surrounding the initial core set and key concepts
for moving forward toward improvement of children’s health
care quality measures, children’s health care quality, and chil-
dren’s health outcomes. The set of articles in this supplement
includes a detailed description of how the identification of
a balanced, grounded, and parsimonious core set of children’s
health care quality measures was accomplished by means of
an open, public process combined with an evidence-informed
evaluation methodology. Additional articles note that Medicaid
and Children’s Health Insurance Program (CHIP) officials put
a high priority on children’s health care quality and desire better
measures; that publicly insured children are more likely than
privately insured children to experience severe, complex
chronic conditions and experience poorer quality in some
respects; and that some key CHIPRA topics did not yet have
valid, feasible measures (eg, availability of services, duration
of enrollment and coverage, most integrated health care
settings, and some aspects of family experiences of care).CADEMIC PEDIATRICS
ublished by Elsevier Inc. on behalf of the Academic Pediatric Associa
S1Key stakeholders and observers provide commentary noting
the unprecedented scope and nature of the CHIPRA legislation
as well as noting areas in which the nation still needs to move to
improve health care quality, including its measurement. These
areas include greater engagement of families and health care
providers in the quality measurement and improvement enter-
prises, collaboration across federal agencies, more emphasis
on clinical effectiveness research to enhance the validity of chil-
dren’s health care services and quality measures, and a need to
maintain an emphasis on children as the nation expands health
care coverage and attention to quality for all populations.
This overview also notes areas of future priorities for measure
enhancement and development, including inpatient specialty,
health outcomes, and a focus on inequity.
We and others contributing to this supplement consider the
identification of the initial core set to be a significant initial
accomplishment under CHIPRA. With sufficient attention to
making the measures feasible for use across Medicaid and
CHIP programs, and with technical assistance, voluntary use
should be facilitated. However, the initial core set is but one
step on the road toward improved quality for children. The iden-
tification of future challenges and opportunities for measure
enhancement will be helpful in setting and implementing
a future pediatric quality research agenda.KEYWORDS: CHIP; CHIPRA; health care quality; measures;
policy
ACADEMIC PEDIATRICS 2011;11:S1–S10THE NEED TO improve children’s health care quality
across all domains (eg, safety, timeliness, effectiveness,
equity, efficiency, patient centeredness, care coordination,
health care delivery system infrastructure capability) is
urgent.1–3 Children in the United States comprise 26%of the nation’s population and account for 1 out of
6 national health expenditure dollars.4 They receive
only 47% of indicated clinical care.5 Racial, ethnic, and
socioeconomic disparities in health care for children
persist, as do differences by health insurance statusVolume 11, Number 3S
tion May–June 2011
S2 DOUGHERTY ET AL ACADEMIC PEDIATRICSand source.6,7 In 2004, 41% of children’s health care
expenditures were paid by public sources; and 12% came
from family out-of-pocket contributions,4 with lower-
income families paying higher shares out of pocket. Health
care events during childhood can and do have both short-
and long-term implications for the productivity and
well-being of children and the nation.8,9 This supplement
to Academic Pediatrics addresses the opportunities in the
recent passage of the Children’s Health Insurance Pro-
gram Reauthorization Act (CHIPRA) to bring a national
focus on children’s health care quality measurement and
improvement.10
CHIPRA provides a compelling architecture for
improving children’s health care quality and outcomes.
The law calls for the identification of an initial coremeasure
set to be used voluntarily to assess the state of children’s
health care quality across and within state Medicaid and
Child Health Insurance Programs (CHIP),11 reporting of
these data to Congress and the public,12 improvement and
strengthening of the initial core measures through grants
and contracts, applicability of core measures across all
public and private programs, the implementation and eval-
uation of a variety of health care quality improvement strat-
egies by States,13 and regular updating of Congress on the
state of children’s health care quality and outcomes.
Although the need to measure and improve quality in
public programs had been addressed previously in legisla-
tion,14 the combination of these areas of quality measure-
ment and improvement in a single piece of national
legislation was unprecedented at the time that CHIPRA
was signed into law. Soon after, the American Recovery
and Revitalization Act (ARRA) included provisions
encouraging the use of health information technology to
measure and improve quality, collect standardized data on
patient demographics, and enhance the evidence base for
health care quality.15 In 2010, the Patient Protection and
Affordable Care Act (ACA)16 expanded quality measure-
ment and improvement provisions similar to those in
CHIPRA for adult populations,17 and added provisions to
makemeasurement and improvement of health care quality
for children more feasible.18–20
This supplement concentrates on the CHIPRA legisla-
tion, focusing in particular on the work used to identify an
initial core set of children’s health care quality
measures11,21–26 and including the views of key
stakeholders concerning the work still ahead to achieve
the CHIPRA goals.13,27–30 Complementary activities
under ARRA and ACA are noted when they will help
extend the reach of CHIPRA, and additional analytic work
is used to help set the stage for identifying additional
priorities in children’s health care quality measurement.
Further, under CHIPRA, the identification of the initial
core set of measures for voluntary use by Medicaid and
CHIP is just a beginning step toward improving quality
measurement and outcomes for children. CHIPRA
provides for a Pediatric Quality Measures Program
(PQMP) to be established by January 1, 2011.31 The
PQMP will work to improve and strengthen the initial
core set, and develop new measures when needed. Topicsfor improvement and development will be identified by
the Department of Health and Human Services (HHS)
with input from the public as to priorities.32 Improved
core sets of children’s health care quality measures are to
be posted annually, beginning January 1, 2013. The ratio-
nale for publishing this supplement is to make publicly
available useful information about issues surrounding the
initial core set, including limitations of the set itself and
key concepts for moving forward toward improvement.
THE INITIAL, RECOMMENDED CORE SET
OF MEASURES
CHIPRA’s requirement for publishing an initial, recom-
mended core set of children’s health care quality measures
for voluntary use by stateMedicaid andCHIP programs and
the health plans and health care providers with which they
engage presented a challenge in terms of timing and scope.
CHIPRA required identification by January 1, 2010, of “the
types of measures that, taken together, can be used to esti-
mate the overall national quality of health care for children
and to perform comparative analyses of pediatric care
quality and racial, ethnic, and socioeconomic disparities
in child health and health care for children.”10 Themeasures
were to be evidence-based, understandable, based on
measures currently in use, and balanced across health
services types and settings, child age groups, and measure
types (structure, process and outcomes), according to the
legislation.10 To facilitate voluntary implementation by as
many state programs as possible, the director of the Centers
for Medicaid and State Operations (CMSO) in the Centers
for Medicare & Medicaid Services (CMS) strongly urged
that the initial core set be both “parsimonious and
grounded,”meaning relatively limited in number and other-
wise feasible for implementation by states.33 As shown in
Table 1, the initial 24 measures posted for public comment
metmany, but not all, of these tests.Measures cover clinical
quality for preventive and treatment services and family
experiences of care across all child age groups. Most of
the measures are process of care indicators, consistent
with health care quality measurement in general, with
only 5 health outcome measures. The measures as a whole
address areas where medical costs are high, consequences
of poor quality are great, and/or there is substantial varia-
tion in performance and/or a high need among racial,
ethnic, low-income, and special health care need popula-
tions of children.
THE SPECIAL ISSUE
The set of articles in this supplement includes a detailed
description of how the identification of a parsimonious set
of children’s health care quality measures for immediate
use was accomplished by a Subcommittee on Children’s
Healthcare Quality Measures for Medicaid and CHIP of
the Agency for Healthcare Research and Quality’s
(AHRQ) National Advisory Council on Healthcare
Research and Quality (SNAC), in close collaboration with
the CMS and a specially convened CHIPRA Federal
Quality Workgroup. An open public process combined
Table 1. Summary of the Initial, Recommended Core Set’s Ability to Address CHIPRA Criteria and Their Relevance to CHIPRA Criteria for Measurement*
CHIPRA-Specified
Measure Topic
CHIPRA Criteria for Measurement
Range of
Child Ages
Range of Health
Care Delivery Settings
and Care Providers
Identification of Disparities
Evidence-Based using
Oxford Centre for
Evidence-Based
Medicine Grade†
Structure,
Process, or
OutcomeBy Race
By
Ethnicity
By
Socioeconomic
Status
By Special
Health Care
Needs Status
(SHCN)
Prevention and health promotion
(13 measures)
All Ambulatory, dental Low birth weight
measure only
Low birth weight
measure only
NA NA 9 with Grade B 2 graded both
B and D; 1 graded D; 1
not able to be graded
12 process,
2 outcome
Treatment and management of
acute conditions (5 measures)
All Ambulatory, dental,
emergency department
(ED), inpatient
NA NA NA NA 2 graded A; 2 graded B;
1 graded D
4 process,
1 outcome
Treatment and management of
chronic conditions (4 measures)
All Ambulatory, ED, mental
health care
NA NA NA Inherently
SHCN
1 graded B; 1 graded C;
2 graded D
4 process
Family experiences of care
(1 measure)
All Ambulatory NA NA NA Yes‡ B Outcome
Availability of services/access 12 mos-
19 years
Ambulatory NA NA NA NA NA Outcome
Most integrated health
care setting
No measures in the initial core set
Duration of enrollment
*CHIPRA ¼ Children’s Health Insurance Program Reauthorization Act (Public Law 111-3, February 4, 2009); NA ¼ data to identify disparities are not available based on current use of the measure;
SNAC ¼ AHRQ National Advisory Council on Healthcare Research and Quality Subcommittee on Children’s Healthcare Quality Measures for Medicaid and CHIP.
†Using the Oxford Centre for Evidence-based Medicine grading system (http://www.cebm.net/?o¼1116), available published evidence was reviewed and grades were assigned as follows. Grade A was
assigned to a measure topic with consistent level 1 studies. Grade B was assigned to a measure topic with consistent level 2 or 3 studies or extrapolations from level 1 studies. Grade C was assigned to
a measure topic with level 4 studies or extrapolations from level 2 or 3 studies. Grade D was assigned to a measure topic with level 5 evidence or troublingly inconsistent or inconclusive studies of any level.
See Mangione-Smith and colleagues11 (this issue) for further explanation of the grading process.
‡The CAHPS Medicaid 4.0 measure of patient experiences of care recommended by the SNAC included the Children With Chronic Care (CCC) items.
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S4 DOUGHERTY ET AL ACADEMIC PEDIATRICSwith an evidence-informed evaluation methodology identi-
fied a balanced, grounded and parsimonious core set of
measures that should be feasible to implement on a wide-
spread basis over time.11
To provide background information for the SNAC’s
consideration of the importance of specific measurement
topics (within the CHIPRA legislative framework), Bethell
was commissioned to analyze data from the 2007 National
Survey of Child Health on the prevalence and incidence of
childhood chronic conditions, and certain aspects of health
care quality. Her article, included in this special issue, finds
that an estimated 43% of US children currently have at
least 1 of 20 chronic conditions, not including overweight
or obesity.21 Rates and severity of chronic conditions are
higher among publicly insured children after controlling
for other demographic and socioeconomic factors, and
variations across States are substantial. Quality of care
varied between children with public versus private insur-
ance on all but 3 measures. Along with data from other
sources,6,7 Bethell’s analysis can provide further
guidance as measure improvement efforts proceed. Hess
and deLone’s analysis of recent survey data provides
a compelling case that CHIPRA’s quality provisions
come at an opportune time for State Medicaid and CHIP
programs. These programs report that health care quality
improvement is relatively high on their list of priorities
and that officials desire better quality measures.23
Four additional articles commissioned during the process
of identifying the initial core set assess the state of the
measurement science for several topics identified as priori-
ties for the legislation. Kenney and Pelletier’s article
addresses measures of duration of enrollment and coverage
in Medicaid and CHIP and confirm that having such
measures is critical to understanding health care quality
within the programs.24 Currently, over 25% of children are
excluded from quality measurement in Medicaid and
CHIP because of differing exclusions based on duration of
enrollment. In her analysis, Bethell also found an almost
5-fold difference across states in gaps in insurance. Kenney
and Pelletier’s article identifies several systems-level
measures of duration with promising validity based on
research studies. However, the SNAC concluded that the
measureswouldneed additional testing beforebeing consid-
ered feasible in real-world Medicaid and CHIP programs,
making thismeasure topic a high priority for future develop-
ment. In addition, further development of durationmeasures
is needed for use with specific quality measures.
CHIPRA also identified measures of availability of
services as a high priority for the core set. Availability
of services for children enrolled in Medicaid has been of
concern since the program began; having valid measures
of availability would complement current measures of real-
ized access (eg, number of members who had at least one
visit with a primary care provider annually34; Table 1)
given that lack of realized access can have multiple deter-
minants other than whether services actually exist (eg,
parental attitudes towards need for care). Kuhlthau’s
article25 identifies several measures of availability that
can be built upon in the future (eg, geographic accessibility,provider willingness to accept insurance type). However,
the article suggests that the subfield of quality measure-
ment development for availability is likely not as far along
as that for other topics. For example, only several subspe-
cialties have been subject to measure development, and
almost all the work has occurred in a research rather than
measure development context.35
CHIPRA also called for measures of the “most integrated
health care setting” for children. In another article commis-
sioned for use by SNAC, Sternberg and colleagues focused
on the medical home as an exemplar of integration and
examined the validity and feasibility of measures of
“medical homeness.”26 The article recommends several
promising approaches to measuring this concept using ex-
isting surveys (eg, Consumer Assessment of Healthcare
Providers and Systems [CAHPS] and the National
Surveys of Child Health) and structural approaches to
measurement (eg, National Committee for Quality Assur-
ance36). However, none of the recommended measures
had been validated for assessing medical homeness at the
time the article was initially prepared. Since then, there
has been more attention to assessing relationships between
medical homeness and desirable child health outcomes,
which could improve the possibility of including a medical
home measure in one of the improved core sets.37–39 In
addition, a broader concept of integration, the pediatric
accountable care organization, was included in the ACA
and will be tested in demonstration projects.40 Developing
and comparing measures of both the medical home and
the pediatric accountable care organization could be
a high priority for the CHIPRA PQMP.
Although SNACwas able to respond to the CHIPRA call
for a measure of family experiences of care by recommend-
ing the CAHPS Medicaid 4.0 for children with chronic
illness for all children, Co and colleagues point out that
work is still needed on measurement of inpatient experi-
ences for children using mental and behavioral health
services and of experiences of care at the clinician-group
level.22 Wells and Partridge point out additional concepts
for further development and testing within the current
family experiences of care measure sets (eg, resolution of
differences of opinions between providers and families;
direct measurement of need for language interpretation).30
Despite the disappointment of not being able to identify
several of the measures identified in the CHIPRA frame-
work, several of the commentaries from key stakeholders
recognize that the process undertaken in 2009, including
the commissioned articles, represented a good beginning
toward improved measurement and improved children’s
health care quality. All commenters point out the need to
go beyond mere measurement. Perspectives from Wells
and Partridge30 and from Palfrey and Brei29 and their
colleagues also identified a need to educate both patients
and providers about the CHIPRA core set and for HHS
to work harder to engage these key stakeholders in both
using and improving the measure sets. As Wells and
Partridge point out, families and child patients have to be
ready to use the data from the core sets to demand better
care. Provider and patient engagement is a key focus of
ACADEMIC PEDIATRICS IMPROVING MEASUREMENT, CARE, AND CHILD AND ADOLESCENT OUTCOMES S5the Pediatric Quality Measurement Program.41 Palfrey and
Brei also note the potential for an evidence-based core set
to improve pay-for-performance approaches to pediatric
quality improvement. Greene-McIntyre and Caldwell
emphasize the need for federal collaboration to avoid intro-
ducing multiple measure sets from different agencies.28
Dougherty and Clancy note the contribution of CHIPRA’S
focus on measurement and improvement to the potential
for transforming children’s health care and health, at the
same time suggesting that more work under other
umbrellas may be needed to enhance the evidence base
for measurement and improvement.27 Finally, Fairbrother
and Simpson make recommendations related to States’
needs for infrastructure and technical assistance and to
the federal government in the context of new quality and
coverage initiatives across the entire US population.18
The remainder of this introductory piece focuses on
setting priorities for measurement.PRIORITIES FOR FUTURE MEASUREMENT
Although the core set is a good start, considerablework is
still needed to improve the initial core set and to develop
evidence-based, feasible measures in areas specified by
CHIPRA. Some of the missing topics are addressed in the
special issue.22,24–26 In addition, our and the SNAC’s
experience during the effort to identify the initial core set
using CHIPRA criteria led to identification of additional
potential priorities for measure development. Some of
these priorities can be accomplished through the PQMP
and others may require effort from elsewhere. Certainly,
States working under the CHIPRA CMS State Quality
Demonstration Projects initiative will make a contribution
and have their measures considered for the improved core
measure sets. These measures will implicitly reflect State
priorities for measure development.
Here we focus on 3 topical areas identified by the SNAC
as potential priorities (inpatient and specialty care and
health outcomes), on inequities in health, and on method-
ological issues uncovered during the SNAC process. We
note why it may be important to focus on these topics,
using standard criteria for assessing importance of a topic
for measurement, ie, incidence, prevalence, costs and other
burdens to the patient, family, and/or society.
INPATIENT CARE
Children ages 0–17 incurred $89.5 billion in inpatient
hospital costs in 2007, over half of which was expected
to be paid by public insurance.42 Although children older
than infancy are less likely than adults to be hospitalized,
quality of inpatient care can have a significant impact on
children’s mortality, morbidity, and costs.43–45
CHIPRA called for a balanced set of measures across
providers and settings. However, the only inpatient quality
measure meeting the criteria for validity, feasibility, and
importance used by the SNAC for the initial core set was
the US Centers for Disease Control and Prevention’s
(CDC) measure for central-line associated blood stream
infection (CLABSI) in pediatric and neonatal intensivecare units (PICU and NICU). Measuring CLABSI in
PICUs and NICUs is very important because infection
puts these most vulnerable children at great risk of death.
Further, CLABSI is not inevitable, and evidence-based
approaches exist to reducing its incidence and sequelae.46
Nonetheless, this patient safety measure represents only
one facet of inpatient care and covers relatively few chil-
dren, and more inpatient measures are needed. In order
to select from among possible topics to choose priorities
within inpatient care, potential measure developers might
consider examining leading causes and costs of child
hospitalization, for example from the AHRQ Healthcare
Cost and Utilization Project (HCUP) databases or the
CDC’s National Hospital Discharge Survey.47,48 As
shown in Table 2, the most costly inpatient conditions are
found in neonates, particularly newborns experiencing
health problems. Beyond the neonatal period, the most
costly inpatient conditions within the top 25 diagnostic
categories are bronchitis and asthma, simple pneumonia
and pleurisy, tracheotomy, other cardiothoracic proce-
dures, and craniotomy. Some of these are costly because
the number of children admitted is relatively large; others
have low admission rates but high costs per admission.
Data on frequency and costs can be complemented by
the increasing literature identifying quality problems in
inpatient care, such as data on neonatal care quality,49 vari-
ations in the extent towhich proven and unproven therapies
are used for common conditions (urinary tract infections,
asthma, bronchiolitis, and gastroenteritis),50 and other
documented quality problems.51–53 Investigation into
quality problems can also be aided by examining patient
and hospital characteristics associated with higher than
average mortality or readmission rates. For example, an
analysis performed by one of us (DD) of the Kids
Inpatient Database using HCUPNet47 reveals that child
inpatient mortality is higher for patients whose likely payer
is uninsured, Medicare, or Medicaid than privately insured
patients, in large hospitals, and in the South compared to
other regions of the country. Differences between public
and private insurance may reflect the fact that public sour-
ces cover many chronically ill children, but the other differ-
ences may point to quality problems that would benefit
from more systematic and regular measurement. As noted
by Co and colleagues, a child inpatient experience of care
measure could address an important domain of quality
across all inpatients.SPECIALTY CARE
Pediatrics is typically thought of as solely a primary care
discipline, but a recent analysis found that 20% of children’s
visits to office-based physicians in the United States are to
specialty providers, including obstetrician-gynecologists,
medical specialists, and surgical specialists.54 Not surpris-
ingly, specialist visit rates are more than twice as high for
children with a chronic condition or disability (26%) as for
children without such conditions or disabilities, but 10%
of children without an identified special health care need
also visited specialists.54 Thus, the quality of specialty
Table 2. Top 25Diagnosis-RelatedGroups, Children Ages 0–17, Ranked by Aggregate Charges, Medicaid as Expected Payer, and Inpatient
Hospital Stays, 2006
Rank
Diagnosis-Related
Group Name
Total No. of
Discharges
Aggregate
Charges, US$
(“National Bill”)*
1 386 Extreme immaturity or respiratory distress syndrome, neonate 41 171 6 138 010 716
2 391 Normal newborn 1 263 747 2 782 436 988
3 387 Prematurity with major problems 35 496 2 245 093 329
4 389 Full term neonate with major problems 82 622 1 951 545 387
5 385 Neonates, died or transferred to another acute care facility 41 365 1 688 920 177
6 98 Bronchitis and asthma age 0–17 154 681 1 440 949 727
7 390 Neonate with other significant problems 264 487 1 280 358 420
8 388 Prematurity without major problems 84 928 1 245 205 194
9 91 Simple pneumonia and pleurisy age 0–17 81 821 904 913 303
10 541 Tracheotomy with mechanical ventilation 96þ hours or principal
diagnoses except face, mouth and neck diagnoses with major
operating room procedure
1 997 762 413 256
11 108 Other cardiothoracic procedures 5 112 738 387 106
12 3 Craniotomy age 0–17 9 554 665 973 288
13 430 Psychoses 37 209 620 137 318
14 475 Respiratory system diagnosis with ventilator support 6 522 596 182 206
15 184 Esophagitis, gastroenteritis and miscellaneous digestive disorders age
0–17
67 373 573 745 831
16 373 Vaginal delivery without complicating diagnoses 71 167 561 992 475
17 26 Seizure and headache age 0–17 33 493 421 896 475
18 110 Major cardiovascular procedures with CC 2 494 408 694 984
19 298 Nutritional and miscellaneous metabolic disorders age 0–17 47 388 398 306 152
20 279 Cellulitis age 0–17 32 524 314 411 091
21 156 Stomach, esophageal, and duodenal procedures age 0–17 10 250 309 979 344
22 542 Tracheotomy with mechanical ventilation 96þ hours or principal
diagnoses except face, mouth and neck diagnoses
without major operating room procedure
981 293 736 656
23 431 Childhood mental disorders 14 011 281 696 261
24 422 Viral illness and fever of unknown origin age 0–17 31 702 271 676 224
25 417 Septicemia age 0–17 8 744 266 980 998
Source: Kids Inpatient Database, 2006, HCUPNet analysis, March 21, 2010.
*Aggregate charges or the “national bill” is the sum of all charges for all hospital stays in the United States. When a case was missing infor-
mation on charges, a value was imputed by taking themean charges for all discharges of the same Diagnosis-Related Group (DRG) with non-
missing charges. Less than 2% of cases aremissing charges in Healthcare Cost and Utilization Project (HCUP) data. Because of howmissing
charges are imputed, simple calculation of number of dischargesmean chargewill not always equal the aggregate charges shown in HCUP-
Net. For the calculation of charges, if length of stay was over 365 days or total charges were over $5 million, the record was dropped from the
Nationwide Inpatient Sample, and if length of stay was missing, total charges were set to missing.
S6 DOUGHERTY ET AL ACADEMIC PEDIATRICScare can have a substantial impact on children’s well-being.
Although relatively little has been published on the costs of
care for rarer conditions, available estimates suggest that
cost is another reason for making specialty care an essential
target of quality measurement and improvement (Table 3).
Efforts to improve quality in selected subspecialty areas55–59
suggest the breadth and depth of quality problems in
specialty care; these efforts can provide building
blocks for further progress in measure development for
accountability by State programs and nationally. For
example, performance measures are being used across
cystic fibrosis centers to assess quality.55 The American
College of Surgeons National Surgical Quality Improve-
ment Program recently initiated assessment of pediatric
surgical outcomes across multiple institutions, finding
a rate of unadjusted complications of from 6.8% to
10.2%.60 Challenges to identification and development of
evidence-based specialty-focused health care quality
measures include the paucity of evidence for much of
subspecialty care27 and relatively small numbers of children
with specific conditions and receiving specific services.61HEALTH OUTCOME MEASURES
Patient health is the ultimate indicator of high quality
health care. High-quality infrastructure and care processes
are precursors to improved or optimal patient outcomes,
such as a healthy full-term birth, age-appropriate body
mass index, recovery from acute illness, and ability to live
aswell as possiblewith chronic illness.62Onedissatisfaction
with the process to identify an initial core set of measures
was the relative paucity of meaningful child health outcome
measures tomeasure health care quality (Table 1). Although
some intermediate outcome measures are used to assess
quality relatively routinely (eg, HbA1c levels reported in
the National Healthcare Quality Reports42), few entities
hold any organizations responsible for individual or child
population health status (eg, number of births to teens,63
child- and family-rated quality of life). However, proxies
such as emergency department and inpatient utilization for
conditions considered to be ambulatory care sensitive are
used, with 2 included in the initial core set (Table 1). Simi-
larly, patient and family experiences of care are a form of
outcome measure shown to be related to health.22
Table 3. Selected Costly Conditions Requiring Specialty Care, Prevalence of Condition, Inpatient Costs, Overall Cost of Illness
Care Type
Prevalence of Condition or
Annual Rate of Health
Care Encounters
Number of Medicaid
Inpatient Discharges
(% of all Discharges Ages 0–17)
and Aggregate Charges,* 2006† Overall Cost of Illness Estimate
Sickle cell disease 1/500 births to African Americans78 13 032 (65.6%)
$197 054 913
$11 075 (median annual)79
Cystic fibrosis 15 000 children80 2 269 (42%)
$116 546 547
$43 000/year (mean medical
expenditures—private only)81
Down syndrome,
ages 0–4
1/800 newborns/year82 NA $36 384/year (mean medical
expenditures–ages 0–4, privately
insured only)83
Spina bifida 1/2500 newborns/year84 NA $49 602 (age <1); $15 242 (ages 1–17);
mean expenditures—privately
insured only)85
Autism spectrum
disorders (ASDs)
About 1 in 110
8-year old children in
multiple areas of the
United States have ASDs86
NA $6830 (mean); $3600 (median)/
year—privately insured only-with
diagnosis in 200387
Oral-facial cleft palate NA NA $22 642 compared to $3900 for an
unaffected child‡ (North Carolina
Medicaid 1995–200288 data);
$36 million in inpatient expenditures,
$85 million in inpatient costs, 2006§
*Aggregate charges or the “national bill” is the sum of all charges for all hospital stays in the United States. When a case was missing infor-
mation on charges, a value was imputed by taking themean charges for all discharges of the same Diagnosis-Related Group (DRG) with non-
missing charges. Less than 2% of cases aremissing charges in Healthcare Cost and Utilization Project (HCUP) data. Because of howmissing
charges are imputed, simple calculation of number of discharges Xmean chargewill not always equal the aggregate charges shown in HCUP-
Net. For the calculation of charges, if length of stay was over 365 days or total charges were over $5 million, the record was dropped from the
Nationwide Inpatient Study, and if length of stay was missing, total charges were set to missing.
†Discharges and aggregate costs are for principal diagnoses only, using the CCS codes in the 2006 Kids Inpatient Database (KID).
‡Outcome measures included average cost per child for medical, inpatient, outpatient, dental, well-child care, mental health, and home
health.
§HCUPNet analysis using KID 2006, for DRG 52 cleft lip and palate repair, March 13, 2010.
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health outcome measures relevant to child health care
quality, those in the field should be aware of the special
challenges inherent in using outcomes to measure health
care quality.64 These challenges are similar to those in
adult medicine, although there may be greater opportuni-
ties for measuring intermediate markers of disease status
in adult than pediatric care (eg, blood pressure, choles-
terol). Recent research strongly suggests causal linkages
between variations in health care quality and changes in
health-related quality of life, some using well-validated
measures such as the PedsQL; further investigation and
testing of health-related quality of life measures may be
warranted under the PQMP.65–67
FOCUS ON INEQUITIES IN HEALTH
Given the persistence of poorer quality for racial, ethnic
and low SES children, and the CHIPRA emphasis on iden-
tifying disparities in quality, an additional approach to
setting priorities for health care qualitymeasurement devel-
opment and improvement might focus on known inequities
in health. For example, a literature review by Berry and
colleagues identified Black children as having higher rates
of cerebral palsy and HIV/AIDs, and surviving less often
with Down syndrome, type 1 diabetes, and traumatic brain
injurywhen comparedwithwhite children.68Hispanic chil-
dren had higher rates of HIV/AIDS and depression, had
poorer glycemic control with type 1 diabetes, and survivedless often with acute leukemia compared with white chil-
dren. Black children are exponentially more likely to
have sickle cell disease or trait; improvements in the quality
of treatment and management of sickle cell enhance the
quality of care for Black children overall. Others have
written compellingly about the need to address pediatric
health disparities.69–71 Working backward from these
differences in health conditions could help identify
potential health care quality problems that could then be
subject to routine measurement. For example, what might
be the role of the health care delivery system in inequities
in early deaths from leukemia among Hispanics?72 Have
quality problems been identified for children with sickle
cell disease?73
Similar strategies might be undertaken for other groups
that are likely to be underrepresented for quality measure
development, such as adolescents.74
METHODOLOGICAL PRIORITIES
Setting priorities for future measurement by clinical
topic or setting will not be sufficient to meet the needs of
children and the directives of the CHIPRA legislation
that measures be applicable across all Medicaid and
CHIP program types (eg, managed care, fee-for-service)
and able to identify disparities by race, ethnicity, socioeco-
nomic status, and special health care need. The effort to
identify initial core measures using CHIPRA requirements
identified a number of critical methodological issues for
S8 DOUGHERTY ET AL ACADEMIC PEDIATRICSfuture measure enhancement and development, including
1) the need for measure specifications that can assess
quality across payers, providers, programs, and patient
populations, and 2) the need to ensure that data needed to
analyze racial, ethnic, socioeconomic, and special health
care need disparities are collected in a consistent way
(beyond disparities identified by a focus on inequities in
health outcomes, as noted above).75 Meeting a third
methodological challenge—to make the best use of
emerging health information technologies for quality
measurement—is crucial for enhancing the feasibility of
the core measures. A fourth is the need to measure the
quality of health care services beyond the traditional
medical care delivery system (eg, hospitals and physi-
cians/nurse offices) into and across specialized therapeutic
services such as mental health, nutrition, physical therapy,
and other rehabilitative services (eg, speech). Addressing
these issues is likely to be a high priority for the CHIPRA
Pediatric Quality Measurement Program (PQMP). Fortu-
nately, the PQMP can build on recent and ongoing efforts
in some of these areas (eg, efforts underway to identify
racial and ethnic disparities; over a decade of experience
with survey-based and other measures to identify children
with special health care needs; and use of electronic health
records to measure quality).LIMITATIONS
The work undertaken to identify the initial core set of
measures and the approach taken in this overview article
to suggest ways to identify priorities has limitations. Limi-
tations of the process to identify initial core measures are
addressed in the article byMangione-Smith and colleagues
in this special issue; these were mostly driven by the short
time available to complete the process.11 For example,
more time and resources might have improved the extent
to which we were able to gather evidence to assess the
underlying validity for a greater variety of CHIPRA topics,
and to gather information on the range of measures avail-
able for consideration by the SNAC. However, in some
respects, the short time frame was advantageous because
it forced the SNAC to complete the process where previous
attempts had struggled.76
We have proposed some ideas for setting priorities for
future measurement work, but other approaches to setting
priorities within children’s health and health care may be
more fruitful. For example, the NQF relied on Bethell’s
identification of child chronic conditions in combination
with a set of priorities previously established by the
National Priorities Project to advise HHS on priorities for
future child health care measure development and endorse-
ment.77 The IOM recently started with a previous IOM
framework and the NPP priorities and added to them the
areas of access and health systems infrastructure capabil-
ities, but they also suggested a more quantitative and
systematic approach as an addendum to their report on
the future of quality measurement reporting.1 Having
a standardized and comprehensive approach to priority
setting often requires standardized and comprehensivedata across a number of domains, a situation that rarely
exists. One advantage that CHIPRA provides the child
health field is the opportunity to set priorities within child
health alone. In many approaches to priority setting, chil-
dren may be disadvantaged relative to adults or subsets
of adults because they comprise only a quarter of the pop-
ulation, incur lower health care expenditures and are less
likely as a group to experience costly chronic conditions.
CONCLUSION
We consider the identification of the core set to be
a significant initial accomplishment under CHIPRA. Valid,
feasible, and important measures for most legislative topics
were identified. With sufficient attention to making the
measures feasible for use across Medicaid and CHIP
programs, and with technical assistance, voluntary use
should be facilitated. This achievement builds on the
efforts of many who have toiled in the children’s health
care quality measurement and improvement fields for
decades. However, the initial core set is but one step on
the road toward improved quality for children. The identi-
fication of future challenges and opportunities for measure
enhancement was a side benefit of the CHIPRA core
measure identification process and has been helpful in
setting a future pediatric quality research agenda.
Improving children’s health care for the benefit of chil-
dren’s andadolescents’ health andwell-being has both short-
and long-term implications for the children, their families,
and society at large. Although quality measurement is not
enough, achieving improvement in children’s health is
inextricably linked to measurement of the quality of health
care that is delivered. Commentaries in this supplement
provide additional detail on how critical it is to go beyond
measurement to continuous quality improvement.13,18 We
are fortunate as a nation that cares for its children that
CHIPRA provides a road map for linking future pediatric
quality measurement and improvement efforts.
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